A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort
, , , e
08 mag 2019
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Research Article
Pubblicato online: 08 mag 2019
Pagine: 219 - 224
Ricevuto: 12 feb 2019
Accettato: 27 mar 2019
DOI: https://doi.org/10.2478/raon-2019-0020
Parole chiave
© 2019 Stefan Janssen, Heinke C Hansen, Liesa Dziggel, Steven E Schild, Dirk Rades, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Janssen, Stefan
Department of Radiation Oncology, University Hospital LubeckLubeck, Germany
Medical Practice for Radiotherapy and Radiation OncologyHannover, Germany
Hansen, Heinke C
Department of Radiation Oncology, University Hospital LubeckLubeck, Germany
Dziggel, Liesa
Department of Radiation Oncology, University Hospital LubeckLubeck, Germany
Schild, Steven E
Department of Radiation Oncology, Mayo Clinic ScottsdaleArizona, U.S.A.
Rades, Dirk
Department of Radiation Oncology, University Hospital LubeckLubeck, Germany